<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04392258</url>
  </required_header>
  <id_info>
    <org_study_id>19-6678-BR</org_study_id>
    <secondary_id>U1111-1251-7468</secondary_id>
    <secondary_id>DRKS00021695</secondary_id>
    <nct_id>NCT04392258</nct_id>
  </id_info>
  <brief_title>Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Cardiopulmonary Resuscitation</brief_title>
  <acronym>Thyro-CPR</acronym>
  <official_title>Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Cardiopulmonary Resuscitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruhr University of Bochum</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ruhr University of Bochum</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Time-limited adaptive responses of thyroid function are common in the critically ill. About
      70% of all patients treated on intensive care units develop a so-called non-thyroidal illness
      syndrome (NTIS) or TACITUS (thyroid allostasis in critical illness, tumours, uraemia and
      starvation), which is marked by low serum concentrations of the thyroid hormone T3 and other
      adaptive reactions of thyroid homeostasis. Occasionally, temporarily elevated concentrations
      of thyrotropin (TSH) and peripheral thyroid hormones are to be observed, especially after
      cardiopulmonary resuscitation (CPR). However, the available evidence is limited, although
      abnormal concentrations of thyroid hormones after CPR have occasionally been reported.

      Aim of the planned study is to investigate the thyrotropic (i.e. thyroid-controlling) partial
      function of the anterior pituitary lobe immediately after CPR. It is intended to evaluate
      statistical measures of TSH concentration and peripheral thyroid hormones in de-identified
      datasets (protocol A). Additionally, a prospective sub-study (protocol B) aims at a more
      precise description of pituitary and thyroid responses by means of serial investigations in
      routine serum samples, both immediately after CPR and during the course of ongoing treatment.
      This includes the evaluation of additional possible predictors, too.

      Primary endpoint of the study is changed TSH concentration immediately after CPR compared to
      the TSH value 24 hours later. Secondary endpoint is the relation between thyroid-controlling
      pituitary function and mortality.

      A high proportion of patients undergoing CPR will eventually receive iodinated radiocontrast
      media (e.g. for computed tomography or coronary angiography). This is one of the reasons why
      early identifying subjects at high risk for possible iodine-induced thyrotoxicosis is
      important. Increased oxygen consumption of the heart in hyperthyroidism is one of the reasons
      for high mortality in thyrotoxicosis. Therefore, accurate diagnosis of alterations in the
      hypothalamus-pituitary-thyroid (HPT) axis is of paramount importance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transient allostatic responses of thyroid function are common in the critically ill. About
      70% of all patients treated on intensive care units develop a so-called non-thyroidal illness
      syndrome (NTIS) or TACITUS (thyroid allostasis in critical illness, tumours, uraemia and
      starvation), which is marked by low serum concentrations of the thyroid hormone T3 and other
      adaptive reactions of thyroid homeostasis. Occasionally, temporarily elevated concentrations
      of thyrotropin (TSH) and peripheral thyroid hormones are to be observed, especially after
      cardio-pulmonary resuscitation (CPR). However, the available evidence is limited, although
      abnormal concentrations of thyroid hormones after CPR have been reported.

      Aim of the planned study is to investigate the thyrotropic partial function of the anterior
      pituitary lobe immediately after CPR. It is intended to evaluate statistical moments of TSH
      concentration and peripheral thyroid hormones in de-identified datasets (protocol A).
      Additionally, a prospective substudy (protocol B) aims at a more precise description of
      pituitary and thyroid responses by means of serial investigations in routine serum samples,
      both immediately after CPR and during the course of ongoing in-patient treatment. This also
      includes the evaluation of additional possible predictors.

      Primary endpoint of the study are changed TSH concentrations immediately after CPR compared
      to the value 24 hours later. Secondary endpoint is the relation between thyrotropic pituitary
      function and mortality.

      A high proportion of patients undergoing CPR will eventually receive iodinated radiocontrast
      media (e.g. for computed tomography or coronary angiography). This is one of the reasons why
      early identifying subjects at high risk for possible iodine-induced thyrotoxicosis is
      important. Increases oxygen consumption of myocardial tissue in hyperthyroidism is one of the
      reasons for high mortality in thyrotoxicosis. Therefore, accurate diagnosis of alterations in
      the hypothalamus-pituitary-thyroid (HPT) axis is of paramount importance.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>TSH response</measure>
    <time_frame>three hours</time_frame>
    <description>Changes in TSH concentration after CPR compared to the value after 24 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prognosis</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Mortality dependent on pituitary thyrotropic partial function</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Heart Arrest</condition>
  <condition>Ventricular Fibrillation</condition>
  <condition>Ventricular Flutter</condition>
  <condition>Ventricular Tachycardia</condition>
  <arm_group>
    <arm_group_label>Status post resuscitation</arm_group_label>
    <description>Patients or dataset that underwent resuscitation</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>TSH determination</intervention_name>
    <description>Determination of serum concentration of thyrotropin (TSH)</description>
    <arm_group_label>Status post resuscitation</arm_group_label>
    <other_name>serum thyrotropin determination</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>FT4 determination</intervention_name>
    <description>Determination of serum free thyroxine (FT4) concentration</description>
    <arm_group_label>Status post resuscitation</arm_group_label>
    <other_name>serum free T4 determination</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>FT3 determination</intervention_name>
    <description>Determination of serum free triiodothyronine (FT3) concentration</description>
    <arm_group_label>Status post resuscitation</arm_group_label>
    <other_name>serum free T3 determination</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>SPINA-GT</intervention_name>
    <description>Calculation of thyroid's secretory capacity (SPINA-GT)</description>
    <arm_group_label>Status post resuscitation</arm_group_label>
    <other_name>GT</other_name>
    <other_name>Thyroid's secretory capacity</other_name>
    <other_name>LOINC 82368-2</other_name>
    <other_name>thyroid's incretory capacity</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>SPINA-GD</intervention_name>
    <description>Calculation of total deiodinase activity (SPINA-GD)</description>
    <arm_group_label>Status post resuscitation</arm_group_label>
    <other_name>GD</other_name>
    <other_name>Sum activity of peripheral deiodinases</other_name>
    <other_name>LOINC 82367-4</other_name>
    <other_name>deiodination capacity</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum aliquots are stored for postponed determination of non-classical thyroid hormones
      including but not limited to thyronamines, 3,5-diiodothyronine (3,5-T2) and reverse T3 (rT3).
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        De-identified datasets (protocol A) or patients (protocol B) admitted to an intensive care
        unit after cardiopulmonary resuscitation (CPR)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admission after cardiopulmonary resuscitation

          -  Minimum age of 18 years

          -  Results of TSH and peripheral thyroid hormone concentrations already available or
             possibility to reorder these investigations in a post-hoc manner if consent has been
             obtained (i. e. time interval after venipuncture within the storage period of the
             central laboratory)

          -  Inclusion after own consent of the patient after reawakening, via custodian or
             independent consultant.

        Exclusion Criteria:

          -  Missing data on thyroid homeostasis in the first blood specimen (obtained before 3
             hours after admission)

          -  Traumatic brain injury

          -  Persistent hints for thyroid dysfunction, not explained by non-thyroidal illness
             syndrome (NTIS) / euthyroid sick syndrome (ESS) / thyroid allostasis in critical
             illness, tumors, uremia and starvation (TACITUS) in consecutive investigations over
             several days after resuscitation

          -  Functionally relevant thyroid or pituitary disorder, as documented in international
             classification of diseases (ICD) codes.

          -  Exposure to radiocontrast agents less than 3 months ago

          -  Therapy with amiodarone (currently or during the previous 3 years)

          -  Pregnancy

          -  Known thyroid disease

          -  Consent not obtained within the routine storage period of the central laboratory

          -  Post-hoc-exclusion if evidence for true dysfunction the the pituitary or the thyroid
             became available during the study period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johannes W Dietrich, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bergmannsheil University Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Johannes W Dietrich, M.D.</last_name>
    <phone>+49-234-302</phone>
    <phone_ext>6400</phone_ext>
    <email>johannes.dietrich@ruhr-uni-bochum.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christine Sievers</last_name>
    <phone>+49-234-302</phone>
    <phone_ext>6400</phone_ext>
    <email>christine.sievers@bergmannsheil.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medizinische Klinik I, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum</name>
      <address>
        <city>Bochum</city>
        <state>NRW</state>
        <zip>D-44789</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Johannes W Dietrich, M.D.</last_name>
      <phone>+49-234-302</phone>
      <phone_ext>6400</phone_ext>
      <email>johannes.w.dietrich@bergmannsheil.de</email>
    </contact>
    <contact_backup>
      <last_name>Harald H Klein, M.D.</last_name>
      <phone>+49-234-302</phone>
      <phone_ext>6400</phone_ext>
      <email>harald.klein@ruhr-uni-bochum.de</email>
    </contact_backup>
    <investigator>
      <last_name>Johannes W Dietrich, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roland Köditz, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christine Fischer-Lahdo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nikolaos Rigas, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Assem Aweimer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer N Siekira</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Viktoria Stab, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Dietrich JW, Stachon A, Antic B, Klein HH, Hering S. The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome. BMC Endocr Disord. 2008 Oct 13;8:13. doi: 10.1186/1472-6823-8-13.</citation>
    <PMID>18851740</PMID>
  </reference>
  <reference>
    <citation>Dietrich JW, Landgrafe G, Fotiadou EH. TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis. J Thyroid Res. 2012;2012:351864. doi: 10.1155/2012/351864. Epub 2012 Dec 30.</citation>
    <PMID>23365787</PMID>
  </reference>
  <reference>
    <citation>Dietrich JW, Müller P, Schiedat F, Schlömicher M, Strauch J, Chatzitomaris A, Klein HH, Mügge A, Köhrle J, Rijntjes E, Lehmphul I. Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling. Eur Thyroid J. 2015 Jun;4(2):129-37. doi: 10.1159/000381543. Epub 2015 May 23.</citation>
    <PMID>26279999</PMID>
  </reference>
  <reference>
    <citation>Dietrich JW, Landgrafe-Mende G, Wiora E, Chatzitomaris A, Klein HH, Midgley JE, Hoermann R. Calculated Parameters of Thyroid Homeostasis: Emerging Tools for Differential Diagnosis and Clinical Research. Front Endocrinol (Lausanne). 2016 Jun 9;7:57. doi: 10.3389/fendo.2016.00057. eCollection 2016.</citation>
    <PMID>27375554</PMID>
  </reference>
  <reference>
    <citation>Chatzitomaris A, Hoermann R, Midgley JE, Hering S, Urban A, Dietrich B, Abood A, Klein HH, Dietrich JW. Thyroid Allostasis-Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming. Front Endocrinol (Lausanne). 2017 Jul 20;8:163. doi: 10.3389/fendo.2017.00163. eCollection 2017. Review.</citation>
    <PMID>28775711</PMID>
  </reference>
  <reference>
    <citation>Müller P, Dietrich JW, Lin T, Bejinariu A, Binnebößel S, Bergen F, Schmidt J, Müller SK, Chatzitomaris A, Kurt M, Gerguri S, Clasen L, Klein HH, Kelm M, Makimoto H. Usefulness of Serum Free Thyroxine Concentration to Predict Ventricular Arrhythmia Risk in Euthyroid Patients With Structural Heart Disease. Am J Cardiol. 2020 Apr 15;125(8):1162-1169. doi: 10.1016/j.amjcard.2020.01.019. Epub 2020 Jan 29.</citation>
    <PMID>32087999</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 7, 2020</study_first_submitted>
  <study_first_submitted_qc>May 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2020</study_first_posted>
  <last_update_submitted>May 22, 2020</last_update_submitted>
  <last_update_submitted_qc>May 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ruhr University of Bochum</investigator_affiliation>
    <investigator_full_name>PD Dr. Johannes W. Dietrich, MD</investigator_full_name>
    <investigator_title>Consultant endocrinologist</investigator_title>
  </responsible_party>
  <keyword>thyroid</keyword>
  <keyword>homeostasis</keyword>
  <keyword>allostasis</keyword>
  <keyword>resuscitation</keyword>
  <keyword>allostatic load</keyword>
  <keyword>critical illness</keyword>
  <keyword>TACITUS</keyword>
  <keyword>NTIS</keyword>
  <keyword>Circulatory arrest</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Ventricular Flutter</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Sharing may be considered upon reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

